JPWO2019123018A5 - - Google Patents
Info
- Publication number
- JPWO2019123018A5 JPWO2019123018A5 JP2020534373A JP2020534373A JPWO2019123018A5 JP WO2019123018 A5 JPWO2019123018 A5 JP WO2019123018A5 JP 2020534373 A JP2020534373 A JP 2020534373A JP 2020534373 A JP2020534373 A JP 2020534373A JP WO2019123018 A5 JPWO2019123018 A5 JP WO2019123018A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- protein
- mev
- heterologous polynucleotide
- gpc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023192505A JP2024009058A (ja) | 2017-12-21 | 2023-11-10 | ラッサワクチン |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762609155P | 2017-12-21 | 2017-12-21 | |
| US62/609,155 | 2017-12-21 | ||
| PCT/IB2018/001620 WO2019123018A2 (en) | 2017-12-21 | 2018-12-20 | Lassa vaccine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023192505A Division JP2024009058A (ja) | 2017-12-21 | 2023-11-10 | ラッサワクチン |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021507707A JP2021507707A (ja) | 2021-02-25 |
| JPWO2019123018A5 true JPWO2019123018A5 (https=) | 2026-01-26 |
| JP2021507707A5 JP2021507707A5 (https=) | 2026-01-26 |
| JP7841847B2 JP7841847B2 (ja) | 2026-04-07 |
Family
ID=65763665
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020534373A Active JP7841847B2 (ja) | 2017-12-21 | 2018-12-20 | ラッサワクチン |
| JP2023192505A Pending JP2024009058A (ja) | 2017-12-21 | 2023-11-10 | ラッサワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023192505A Pending JP2024009058A (ja) | 2017-12-21 | 2023-11-10 | ラッサワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11976305B2 (https=) |
| EP (1) | EP3727411A2 (https=) |
| JP (2) | JP7841847B2 (https=) |
| KR (1) | KR102822230B1 (https=) |
| CN (1) | CN111886342B (https=) |
| AU (1) | AU2018392826B2 (https=) |
| CA (1) | CA3085224A1 (https=) |
| MX (1) | MX2020006476A (https=) |
| SG (1) | SG11202004899SA (https=) |
| WO (1) | WO2019123018A2 (https=) |
| ZA (1) | ZA202003070B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111206022A (zh) * | 2020-02-20 | 2020-05-29 | 中国人民解放军军事科学院军事医学研究院 | 一种表达拉沙热病毒空衣壳的重组病毒及其制备方法 |
| KR102404143B1 (ko) * | 2020-04-21 | 2022-05-31 | 대한민국(질병관리청장) | 라싸 바이러스 핵단백질에 특이적인 항체, 이를 생산하는 하이브리도마 세포주 및 이를 이용한 라싸 바이러스 검출 키트 |
| TWI815572B (zh) * | 2021-09-27 | 2023-09-11 | 美商圖策智能科技有限公司 | 特定病毒的突變耐受表位的推估方法及系統 |
| WO2026013289A1 (en) * | 2024-07-12 | 2026-01-15 | Institut Pasteur | Measles-mumps-rubella (mmr) vaccines |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE181112T1 (de) | 1995-08-09 | 1999-06-15 | Schweiz Serum & Impfinst | Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren |
| EP1375512B1 (en) | 2002-06-20 | 2009-07-22 | Institut Pasteur | Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions |
| WO2005012538A2 (en) * | 2003-08-01 | 2005-02-10 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Accelerated vaccination |
| ES2423518T3 (es) | 2006-12-22 | 2013-09-20 | Institut Pasteur | Células y metodología para generar virus de ARN de cadena de sentido negativo no segmentada |
| CA2774475A1 (en) | 2009-09-16 | 2011-03-24 | The Administrators Of The Tulane Educational Fund | Lassa virus-like particles and methods of production thereof |
| EP3662935A1 (en) | 2011-07-11 | 2020-06-10 | Inovio Pharmaceuticals, Inc. | Cross-protective arenavirus vaccines and their method of use |
| US11701418B2 (en) * | 2015-01-12 | 2023-07-18 | Geovax, Inc. | Replication-deficient modified vaccinia Ankara (MVA) expressing Ebola virus glycoprotein (GP) and matrix protein (VP40) |
| EP3103474A1 (en) * | 2015-06-12 | 2016-12-14 | Institut Pasteur | Live recombinant measles-m2 virus and its use in eliciting immunity against influenza viruses |
-
2018
- 2018-12-20 EP EP18857393.5A patent/EP3727411A2/en active Pending
- 2018-12-20 MX MX2020006476A patent/MX2020006476A/es unknown
- 2018-12-20 JP JP2020534373A patent/JP7841847B2/ja active Active
- 2018-12-20 CA CA3085224A patent/CA3085224A1/en active Pending
- 2018-12-20 WO PCT/IB2018/001620 patent/WO2019123018A2/en not_active Ceased
- 2018-12-20 KR KR1020207021052A patent/KR102822230B1/ko active Active
- 2018-12-20 SG SG11202004899SA patent/SG11202004899SA/en unknown
- 2018-12-20 US US16/954,592 patent/US11976305B2/en active Active
- 2018-12-20 CN CN201880082649.9A patent/CN111886342B/zh active Active
- 2018-12-20 AU AU2018392826A patent/AU2018392826B2/en active Active
-
2020
- 2020-05-25 ZA ZA2020/03070A patent/ZA202003070B/en unknown
-
2023
- 2023-11-10 JP JP2023192505A patent/JP2024009058A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023134488A5 (https=) | ||
| AU2001293222B2 (en) | Packaging of positive-strand RNA virus replicon particles | |
| EP1375512B1 (en) | Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions | |
| JP6251273B2 (ja) | チクングニアウイルスポリペプチドを発現する組換え麻疹ウイルスおよびその適用 | |
| Radecke et al. | Reverse genetics meets the nonsegmented negative-strand RNA viruses | |
| WO1997016539A1 (en) | Recombinant sendai virus | |
| JP2010530245A5 (https=) | ||
| AU2002303330A1 (en) | Chimeric alphavirus replicon particles | |
| WO2002099035A2 (en) | Chimeric alphavirus replicon particles | |
| JP2005515755A5 (https=) | ||
| JP2004501646A5 (https=) | ||
| CN110079541A (zh) | 一种构建冠状病毒感染性克隆的方法及其应用 | |
| JP2020524496A5 (https=) | ||
| JP2023525785A (ja) | 安定化コロナウイルススパイクタンパク質をコードするｒｎａレプリコン | |
| Atasheva et al. | Pseudoinfectious Venezuelan equine encephalitis virus: a new means of alphavirus attenuation | |
| CN111218477B (zh) | 靶向感染哺乳动物细胞的禽4型腺病毒载体及其应用 | |
| JP2025169275A5 (https=) | ||
| CN105378090B (zh) | 呼吸道合胞病毒半活疫苗 | |
| JPWO2019123018A5 (https=) | ||
| JP2011507515A5 (https=) | ||
| EP3865180A1 (en) | Live recombinant measles virus expressing coronavirus antigens - its use in eliciting immunity against coronaviruses | |
| JPWO2021216776A5 (https=) | ||
| CN113604496A (zh) | 利用烟草脆裂病毒同时表达两种外源蛋白的载体构建法 | |
| CN116785422B (zh) | 含有新型冠状病毒联合抗原的麻疹减毒疫苗及其拯救方法 | |
| US7179457B2 (en) | Modified nodavirus RNA for gene delivery |